| |
| |
|
| Insider
Information: |
Mueller Brian |
| Relationship: |
|
| City: |
Novato |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
81,859 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,368,863 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
81,859 |
|
|
| Total
Value |
$6,368,863 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biomarin Pharmaceutical Inc |
BMRN |
EVP, Chief Financial O... |
2024-03-15 |
71,859 |
|
0 |
Premium* |
|
|
Anthera Pharmaceuticals Inc |
ANTH |
|
2015-12-23 |
10,000 |
2015-12-23 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
136 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2012-05-22 |
4 |
D |
$37.98 |
$2,127 |
D/D |
(56) |
15,340 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2012-05-12 |
5 |
D |
$38.00 |
$21,812 |
D/D |
(574) |
15,036 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2012-07-02 |
4 |
AS |
$40.00 |
$110,800 |
D/D |
(2,770) |
15,340 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2012-07-10 |
4 |
AS |
$42.50 |
$106,250 |
D/D |
(2,500) |
15,340 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2012-11-05 |
4 |
AS |
$46.00 |
$376,250 |
D/D |
(8,000) |
15,340 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2012-11-15 |
4 |
AS |
$50.00 |
$790,600 |
D/D |
(15,812) |
15,340 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2015-04-30 |
4 |
A |
$51.26 |
$31,117 |
D/D |
607 |
13,407 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2015-10-31 |
5 |
A |
$51.26 |
$6,510 |
D/D |
127 |
12,053 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2016-04-29 |
4 |
A |
$51.26 |
$16,763 |
D/D |
327 |
15,574 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2014-05-08 |
4 |
D |
$56.78 |
$25,210 |
D/D |
(444) |
8,281 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2014-05-15 |
4 |
D |
$57.44 |
$11,890 |
D/D |
(207) |
8,290 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2014-05-31 |
4 |
D |
$57.96 |
$17,214 |
D/D |
(297) |
7,993 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2014-05-12 |
4 |
D |
$59.30 |
$16,723 |
D/D |
(282) |
8,497 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2013-03-01 |
4 |
S |
$59.74 |
$300,067 |
D/D |
(5,023) |
15,294 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2013-03-01 |
4 |
S |
$59.81 |
$120,510 |
D/D |
(2,015) |
13,279 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Acting CFO |
• – – |
2019-10-31 |
4 |
A |
$62.23 |
$560 |
D/D |
9 |
13,968 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2021-04-30 |
4 |
A |
$62.41 |
$21,281 |
D/D |
341 |
31,357 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2013-05-31 |
4 |
D |
$62.70 |
$25,895 |
D/D |
(413) |
8,447 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2022-12-13 |
4 |
OE |
$63.10 |
$157,750 |
D/D |
2,500 |
30,246 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2023-01-13 |
4 |
OE |
$63.10 |
$157,750 |
D/D |
2,500 |
30,246 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2013-05-08 |
4 |
D |
$65.32 |
$31,288 |
D/D |
(479) |
8,924 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2013-05-02 |
4 |
S |
$65.35 |
$610,354 |
D/D |
(9,331) |
9,403 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2013-05-03 |
4 |
S |
$67.11 |
$503,295 |
D/D |
(7,500) |
9,403 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2013-05-12 |
4 |
D |
$67.68 |
$55,295 |
D/D |
(817) |
8,107 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2022-08-05 |
4 |
OE |
$67.81 |
$237,335 |
D/D |
3,500 |
34,226 |
0 |
- |
|
136 Records found
|
|
Page 3 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
